Home
Conditions
Fallopian Tube Diseases

Clinical trial condition

Fallopian Tube Diseases

Explore clinical trials studying Fallopian Tube Diseases. Study availability and eligibility vary by location and protocol.

598 public trials 89 recruiting studies

Refine in advanced search Browse all conditions

Fallopian Tube Diseases trial results

Completed

Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT00003345

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Cervical Cancer

NCT00049556

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +26 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Irofulven in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT00019552

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Medicine Branch Bethesda, Maryland, United States

View Trial Details

Completed

Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00019461

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT00006041

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Taurolidine in Treating Patients With Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00021034

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Bicalutamide and Goserelin in Treating Patients With Cancer of the Ovary, Fallopian Tube, or Peritoneum

NCT00012090

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

NCT00058435

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

CT-2103 in Treating Patients With Recurrent Ovarian Epithelial or Fallopian Tube Cancer or Primary Peritoneal Cancer

NCT00017017

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer

NCT00003967

Conditions: Adnexal Diseases, Brenner Tumor, Carcinoma, +26 more
Locations: Holden Comprehensive Cancer Center at The University of Iowa Iowa City, Iowa, United States

Mercy Medical Center, Inc. Baltimore, Maryland, United States

Cooper Hospital/University Medical Center Camden, New Jersey, United States

Ireland Cancer Center Cleveland, Ohio, United States

View Trial Details

Fallopian Tube Diseases

Fallopian Tube Diseases trial results

Related conditions